Weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer a protective shield against serious ...

Newly published research claims those taking GLP-1 jabs are at a 37 percent lower risk of dementia than those on the anti-diabetic medication.

A new scientific study has found that weight loss jabs such as Mounjaro and Ozempic can help protect against serious health issues like dementia ...

Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.

For people who are obese and have type 2 diabetes, using Ozempic and other GLP-1 agonist drugs cuts the all-cause mortality rate by 30%, according to a new Use of GLP-1 agonists also cut the risk that ...

Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...

A new study of 60,000 people around the world is shedding light on the possible brain health benefits of popular weight-loss drugs like Ozempic and Wegovy, specifically for their potential to ...

A new study found weight loss injections may help reduce the risk of dementia and stroke in people who are obese and have ...

Over seven years, those taking medication such as Ozempic and Mounjaro - were less likely to develop these brain issues or die prematurely. But Edinburgh University's Professor Tara Spires-Jones told ...

Researchers say findings indicate the drugs offer neuroprotective benefits beyond glucose control and weight loss. Experts say it’s a link that needs further study. Doctors have found a way to ...

People who use GLP-1 weight loss drugs like Ozempic are more likely to suffer from severe acid reflux, or GERD, a new ...

Blockbuster weight loss drugs like Ozempic, Wegovy and Mounjaro may slash the risk of a disorder affecting nearly 7million Americans by 45 percent, a study from Ireland suggests.